Aeolus Pharms Inc

(AOLS)

By |

Profile

Aeolus Pharmaceuticals Inc is a Southern California based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.

Contact Information

Website: www.aolsrx.com
Email: Info@aolsrx.com
Main Phone: +1 949 481-9825
Address: 26361 Crown Valley Parkway
Address 2: Suite 150
State: CA
City / Town: Mission Viejo
Country: USA
Postal Code: 92691

Issuer Information

Exchange: OTO
CEO: John L. McManus
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

Profile

Aeolus Pharmaceuticals Inc is a Southern California based biopharmaceutical company. The company is developing a platform of novel compounds for use in biodefense, fibrosis, oncology, infectious disease and diseases of the central nervous system. Aeolus is developing its lead compound, AEOL-10150, as a treatment for the lung effects of Acute Radiation Syndrome (Lung-ARS). Aeolus also has two pre-clinical development programs: AEOL 11114 and AEOL 20415.

Contact Information

Website: www.aolsrx.com
Email: Info@aolsrx.com
Main Phone: +1 949 481-9825
Address: 26361 Crown Valley Parkway
Address 2: Suite 150
State: CA
City / Town: Mission Viejo
Country: USA
Postal Code: 92691

Issuer Information

Exchange: OTO
CEO: John L. McManus
Employees: 4
NAICS: Pharmaceutical Preparation Manufacturing(325412)

Equities News

$ 0.0018 $ 0. (0.00%)
Last Price 0.0018 Change $ 0. Change % 0.00 Tick N/A
Bid 0.0012 Bid Size 99,968.00 Ask 0.25 Ask Size 2,500.00
Open N/A High N/A Low N/A Prev Close 0.0018
Last Trade Volume 0 52 Wk Hi 0.01 52 Wk Low 0.01
Market Cap 273,754 Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 152,085,825.00 EPS (TTM) -0.04 PE Ratio N/A Exchange OTCPK
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Russell L. Skibsted 1,000
Joseph J. Krivulka 1,000
John L. McManus 1,000
John L. McManus 1,000
Russell L. Skibsted 1,000
Russell L. Skibsted 1,000
Russell L. Skibsted 1,000
John L. McManus 1,000
John L. McManus 1,000
John L. McManus 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.25 1.25 1.25 1.25
Low Target Price Estimate 1.25 1.25 1.25 1.25
Mean Target Price Estimate 1.25 1.25 1.25 1.25
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 12/01/15 12/01/15 12/01/15 12/01/15
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1